Glycostem Competitors and Similar CompaniesClear all

Glycostem's competitors and similar companies include Triumvira, IMV, LIfT BioSciences and Mirati Therapeutics.

	Glycostem Glycostem is a company specializing in allogeneic cellular immunotherapy.	Triumvira Triumvira Immunologics is an immunotherapy company.	IMV IMV is a clinical-stage immuno-oncology company.	LIfT BioSciences LIfT BioSciences is a biotechnology company that specializes in allogeneic neutrophil-based cell therapies.	Mirati Therapeutics Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer.
Founding Date	Founding Date 2007	Founding Date 2015	Founding Date 2000	Founding Date 2016	Founding Date 2013
Type	Type Private	Type Private	Type Private	Type Private	Type Subsidiary
Tags	Tags Healthcare biotech clinical research oncology platform therapy	Tags Healthcare biotech drug development life sciences pharma therapy	Tags Healthcare biotech clinical research oncology therapy	Tags Healthcare biotech clinical research oncology therapy	Tags Healthcare biotech clinical research drug development oncology therapy
Locations	Locations Oss, NL HQ	Locations Austin, US HQ Hamilton, CA	Locations Dartmouth, CA HQ Québec, CA	Locations HQ	Locations San Diego, US HQ Zug, CH
Employees	Employees 27	Employees 287% decrease	Employees 63	Employees 209% decrease	Employees 666% decrease
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $12.4m (FY, 2022)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $600k (FY, 2022)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit $11.8m (FY, 2022)
Net income	Net income N/A	Net income N/A	Net income ($38m) (FY, 2022)	Net income N/A	Net income ($740.9m) (FY, 2022)
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 55m (almost 6 years ago)	Latest funding round $ 4.2m (over 12 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised N/A	Total funding raised $ 55m	Total funding raised $ 4.2m	Total funding raised N/A	Total funding raised N/A